Silver patch may shield fragile newborns from deadly infections
NCT ID NCT00964093
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a special silver dressing (Algidex) placed over central line insertion sites can prevent bloodstream infections in very low birth weight infants (500-1500 grams). Researchers compared infection rates, hospital stay length, and safety between babies who got the silver dressing and those who received standard care. The trial involved 100 infants in the NICU.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL LINE BLOODSTREAM INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor University Medical Center - Women and Children's Services
Dallas, Texas, 75204, United States